Ou Li is an accomplished pharmacology professional with extensive experience in the biopharmaceutical industry. Currently serving as Director of Pharmacology at Nutcracker Therapeutics since March 2021, Ou Li leads preclinical efforts to advance multimodal mRNA therapeutics towards IND submission. Previously, Ou Li held positions as Senior Scientist at Hengenix, Pharmacologist at Five Prime Therapeutics, and Senior Scientist I at XOMA, contributing significantly to various innovative therapeutic approaches, including bispecific antibodies and antibody development. Academic training includes a PhD in Immunology from The Ohio State University College of Medicine and a Bachelor of Medicine in Immunology from Beijing Medical University.
This person is not in any teams